ABCG2 and pancreatic neoplasm: We confirmed ABCG2 overexpression in three pancreatic cancer lines resulted in resistance to chemotherapy and we showed that chemical inhibition of ABCG2 can reverse resistance in vitro, but its clinical relevance is unclear given a lack of strong correlation with patient outcomes.